News and blogs

New evidence shows that people with untreated or unsuppressed HIV are at risk of severe disease and death from mpox

Despite being at heightened risk of HIV and STIs, new research finds that gay and bisexual men in India lack the information and services they need to protect their health

South African study finds no link between PrEP use during pregnancy and preterm births or small infant size at birth

Study involving 280,000 women and girls in sub-Saharan Africa finds that partner violence increases women’s risk of getting HIV and decreases their chances of viral suppression

Young women in South Africa who see HIV as a punishment for promiscuity are less likely to see themselves as being at risk, new study suggests

Effective public health measures have brought mpox under control in high-income countries, but it is still an issue elsewhere, particularly in west and central Africa

New global alliance announces plans to step up action over the next seven years, with an initial focus on 12 African countries

The Mosaico HIV vaccine trial has been stopped because some people who were given the vaccine still got HIV. Where does HIV vaccine research go from here?

Caribbean programme that formed partnerships between healthcare providers and people with HIV significantly improved HIV care

HIV prevalence is three times higher among men who have sex with men in African countries that criminalise homosexuality compared to those that don’t

District-level data from 40 African countries reveal significant differences in HIV prevalence by age and sex

Women who sell sex in Nsanje, Malawi show a high-level of engagement with HIV treatment due to the existence of peer-led services

Findings from Zambia from the first ever PrEP study in prisons – in Africa or anywhere – has reported uptake of 93%

South African study finds 90% of people with HIV referred through a community-based scheme completed preventative TB treatment – 11% more than people in standard HIV care

Modelling from sub-Saharan Africa suggests male circumcision should continue for the next five years at least, despite increased access to HIV treatment and PrEP

A number of African countries have now approved a vaginal ring that contains the antiretroviral drug dapivirine, which women can use to stop themselves from getting HIV.